TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 83.20
-1.80 (-2.12%)
At close: Dec 5, 2025
TTY Biopharm Company Market Cap
TTY Biopharm Company has a market cap or net worth of 20.69 billion as of December 5, 2025. Its market cap has increased by 12.58% in one year.
Market Cap
20.69B
Enterprise Value
20.70B
Revenue
6.50B
Ranking
n/a
PE Ratio
11.57
Stock Price
83.20
Market Cap Chart
Since July 3, 2003, TTY Biopharm Company's market cap has increased from 3.05B to 20.69B, an increase of 578.47%. That is a compound annual growth rate of 8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 20.69B | 14.29% |
| Dec 31, 2024 | 18.10B | -9.45% |
| Dec 29, 2023 | 19.99B | -3.60% |
| Dec 30, 2022 | 20.74B | 21.22% |
| Dec 30, 2021 | 17.11B | 0.29% |
| Dec 31, 2020 | 17.06B | -16.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 259.78B |
| PharmaEssentia | 189.73B |
| Heron Neutron Medical | 95.61B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Lin BioScience | 34.45B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 32.34B |